184 related articles for article (PubMed ID: 17537301)
21. Depression and lipoprotein lipids in healthy, postmenopausal women; the moderating effects of hormone replacement therapy.
Brown RA; Giggey PP; Dennis KE; Waldstein SR
J Psychosom Res; 2004 Aug; 57(2):171-6. PubMed ID: 15465072
[TBL] [Abstract][Full Text] [Related]
22. [The influence of the hormonal replacement therapy on conjunctival epithelium morphology among peri- and postmenopausal women].
Okoń A; Jurowski P; Goś R
Klin Oczna; 2001; 103(4-6):183-6. PubMed ID: 11975014
[TBL] [Abstract][Full Text] [Related]
23. Breast cancer in postmenopausal women with and without hormone replacement therapy: preliminary results of the MISSION study.
Espié M; Mares P; de Reilhac P; Chevallier T; Daurès JP
Gynecol Endocrinol; 2006 Aug; 22(8):423-31. PubMed ID: 17012103
[TBL] [Abstract][Full Text] [Related]
24. Treatment of depression and anxiety in infertile women: cognitive behavioral therapy versus fluoxetine.
Faramarzi M; Alipor A; Esmaelzadeh S; Kheirkhah F; Poladi K; Pash H
J Affect Disord; 2008 May; 108(1-2):159-64. PubMed ID: 17936366
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis.
Dane C; Dane B; Cetin A; Erginbas M
Gynecol Endocrinol; 2007 Jul; 23(7):398-403. PubMed ID: 17701771
[TBL] [Abstract][Full Text] [Related]
26. [Effect of combined continued hormone replacement therapy on knee osteoarthritis symptom of postmenopausal women].
Song YJ; Lin SQ; Wu ZH; Weng XS; Qiu GX; Chen FL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Oct; 26(5):571-5. PubMed ID: 15562775
[TBL] [Abstract][Full Text] [Related]
27. Bone mass measurement and factors associated with risk of fracture in a group of peri- and postmenoupausal women.
Rasheed A; Khurshid R; Aftab L
J Ayub Med Coll Abbottabad; 2008; 20(1):48-51. PubMed ID: 19024185
[TBL] [Abstract][Full Text] [Related]
28. [Effect and safety evaluation of catgut implantation at acupoint for levels of bone metabolism and free radicals in postmenopausal women].
Chen GZ; Xu YX; Zhang JW; Liu SH; Guo ZY
Zhongguo Zhen Jiu; 2010 Mar; 30(3):177-81. PubMed ID: 20496728
[TBL] [Abstract][Full Text] [Related]
29. Continuous combined hormone replacement therapy relieves climacteric symptoms and improves health-related quality of life in early postmenopausal women.
Pitkin J; Smetnik VP; Vadász P; Mustonen M; Salminen K; Ylikangas S;
Menopause Int; 2007 Sep; 13(3):116-23. PubMed ID: 17785037
[TBL] [Abstract][Full Text] [Related]
30. Different effects of tibolone and low-dose EPT in the management of postmenopausal women with primary headaches.
Nappi RE; Sances G; Sommacal A; Detaddei S; Facchinetti F; Cristina S; Polatti F; Nappi G
Menopause; 2006; 13(5):818-25. PubMed ID: 16894336
[TBL] [Abstract][Full Text] [Related]
31. Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder.
Jazayeri S; Tehrani-Doost M; Keshavarz SA; Hosseini M; Djazayery A; Amini H; Jalali M; Peet M
Aust N Z J Psychiatry; 2008 Mar; 42(3):192-8. PubMed ID: 18247193
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation on the compliance of livial therapy in peri and postmenopausal women].
Bai W; Yang X; Wang Y
Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):219-21. PubMed ID: 11776164
[TBL] [Abstract][Full Text] [Related]
33. The effect of physicians' advice and recommendations on the compliance with hormone replacement therapy in the treatment of postmenopausal symptoms in Japanese women--a prospective study.
Ushiroyama T; Ikeda A; Sakuma K; Ueki M
J Med; 2004; 35(1-6):163-9. PubMed ID: 18084874
[TBL] [Abstract][Full Text] [Related]
34. Effect of hormone replacement therapy on heart rate variability in postmenopausal women.
Zhang H; Bai W; Guo J; Zheng S; Zhao J
Chin Med J (Engl); 2000 Jul; 113(7):592-4. PubMed ID: 11776024
[TBL] [Abstract][Full Text] [Related]
35. Optimizing the ability of the Hamilton Depression Rating Scale to discriminate across levels of severity and between antidepressants and placebos.
Santor DA; Debrota D; Engelhardt N; Gelwicks S
Depress Anxiety; 2008; 25(9):774-86. PubMed ID: 17935212
[TBL] [Abstract][Full Text] [Related]
36. A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women.
Endrikat J; Graeser T; Mellinger U; Ertan K; Holz C
Maturitas; 2007 Oct; 58(2):201-7. PubMed ID: 17889463
[TBL] [Abstract][Full Text] [Related]
37. [Occurrence of depression symptoms and their influence factors in perimenopausal women].
Zhao G; Bao Y; Qu C
Zhonghua Fu Chan Ke Za Zhi; 1996 Oct; 31(10):614-6. PubMed ID: 9275458
[TBL] [Abstract][Full Text] [Related]
38. Is psychotherapy a reliable alternative to pharmacotherapy to promote the mental health of infertile women? A randomized clinical trial.
Faramarzi M; Kheirkhah F; Esmaelzadeh S; Alipour A; Hjiahmadi M; Rahnama J
Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):49-53. PubMed ID: 18848381
[TBL] [Abstract][Full Text] [Related]
39. Estrogen replacement in perimenopause-related depression: a preliminary report.
Schmidt PJ; Nieman L; Danaceau MA; Tobin MB; Roca CA; Murphy JH; Rubinow DR
Am J Obstet Gynecol; 2000 Aug; 183(2):414-20. PubMed ID: 10942479
[TBL] [Abstract][Full Text] [Related]
40. Neurophysiologic changes during estrogen augmentation in perimenopausal depression.
Morgan ML; Cook IA; Rapkin AJ; Leuchter AF
Maturitas; 2007 Jan; 56(1):54-60. PubMed ID: 16835012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
